-10%
Rosuva EZ 30 Tablet
Rosuvastatin reduces LDL production and the number of LDL particles.
:
Out of stock
In stock – ready to ship
Delivery
Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days
Cash on Delivery
Pay when you receive your order.
Returns
Easy 7-day return & exchange
- Category
- Tablet & Capsules
- Brand
- Square Pharmaceuticals PLC
Product details
Rosuva EZ 30 Tablet
Rosuvastatin, an HMG CoA-reductase inhibitor (statin), and Ezetimibe, a dietary cholesterol absorption inhibitor, combination is indicated in adults:
- As an adjunct to diet in patients with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C).
- Alone or as an adjunct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.
Pharmacology
Rosuvastatin: Rosuvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of hepatic LDL receptors on the cell-surface to enhance uptake and catabolism of LDL; Rosuvastatin reduces LDL production and the number of LDL particles.
Interaction
The concomitant use of Rosuvastatin & Ezetimibe combination with Cyclosporine or Gemfbrozil is not recommended.Rosuvastatin & Ezetimibe combination dosage modifcations are recommended for patients taking certain antiviral medications, Darolutamide, and Regorafenib.
Contraindications
Contraindicated in patients with:Active liver disease or decompensated cirrhosisHypersensitivity to any component
Side Effects
Common side efects are headache, nausea, myalgia, arthralgia, dizziness, asthenia, constipation, abdominal pain, respiratory tract infection, diarrhea, sinusitis, pain in extremity, fatigue, infuenza and back pain.
Pregnancy & Lactation
This preparation is contraindicated in women who are or may become pregnant. Breastfeeding is not recommended.
Precautions & Warnings
Myopathy and rhabdomyolysis: Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs and higher dosage. Discontinue if markedly elevated creatine kinase (CK) levels occur or myopathy is diagnosed or suspected.
Use in Special Populations
Patients with Hepatic Impairment: Contraindicated in patients with acute liver failure or decompensated cirrhosis. If serious hepatic injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs, promptly discontinue the medicine.
Therapeutic Class
Other lipid regulating drugs
Storage Conditions
Store below 30°C. Protect from light and moisture. Keep all medicine out of the reach of children.
0 reviews
⭐
No reviews yet
Bought this product? Share your experience to help others.
You may also like
Recently viewed
Rosuva EZ 30 Tablet
৳750